Cargando…

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report

Triple negative breast carcinoma is a problematic subtype with poor outcomes. Many clinical trials are underway to find possible target to increase treatment options. Epidermal growth factor receptor (EGFR) has emerged as one such molecule which is over expressed in some of these patients and can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Gunjesh Kumar, Bajpai, Jyoti, Joshi, Shalaka, Prabhash, Kumar, Choughule, Anuradha, Patil, Asawari, Gupta, Sudeep, Badwe, Rajendra Achyut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498275/ https://www.ncbi.nlm.nih.gov/pubmed/33014134 http://dx.doi.org/10.3332/ecancer.2020.1092

Ejemplares similares

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
por: Joshi, Asim, et al.
Publicado: (2022)

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
por: Ramteke, Manoj P., et al.
Publicado: (2016)

Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience
por: Bhargava, Prabhat, et al.
Publicado: (2022)

Billiary obstruction in a metastatic tumor of the pancreas from breast cancer
por: Jyoti, Bajpai, et al.
Publicado: (2017)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
por: Patil, Vijay Maruti, et al.
Publicado: (2017)

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
por: Noronha, Vanita, et al.
Publicado: (2017)

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer
por: Patil, Vijay, et al.
Publicado: (2019)

Taxane Combination Chemotherapy in Breast Cancer: Experience from a Tertiary Cancer Centre in India
por: Bajpai, Jyoti, et al.
Publicado: (2017)

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients
por: Noronha, Vanita, et al.
Publicado: (2014)

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
por: Bajpai, Jyoti, et al.
Publicado: (2022)

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
por: Joshi, Amit, et al.
Publicado: (2017)

Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal
por: Noronha, Vanita, et al.
Publicado: (2015)

Mammographic screening for breast cancer: Are the chickens coming home to roost?
por: Badwe, Rajendra A., et al.
Publicado: (2013)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Sentinel Node Biopsy Versus Low Axillary Sampling in Predicting Nodal Status of Postchemotherapy Axilla in Women With Breast Cancer
por: Parmar, Vani, et al.
Publicado: (2020)

The COVID-19 Pandemic and Cancer Surgery
por: Pramesh, C. S., et al.
Publicado: (2021)

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
por: Noronha, Vanita, et al.
Publicado: (2013)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
por: Veldore, Vidya H, et al.
Publicado: (2018)

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
por: Choughule, A, et al.
Publicado: (2014)

Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre
por: Bondili, Suresh Kumar, et al.
Publicado: (2022)

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
por: Kate, Shruti, et al.
Publicado: (2019)

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospective pilot analysis and viewpoint
por: Bajpai, Jyoti, et al.
Publicado: (2017)

Epidemiology of rare cancers in India and South Asian countries – remembering the forgotten
por: Mailankody, Sharada, et al.
Publicado: (2023)

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
por: Behel, Vichitra, et al.
Publicado: (2022)

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity
por: Chougule, Anuradha, et al.
Publicado: (2013)

National Cancer Control Programme in India: Proposal for Organization of Chemotherapy and Systemic Therapy Services
por: Gulia, Seema, et al.
Publicado: (2016)

Evaluation of 1-Year vs Shorter Durations of Adjuvant Trastuzumab Among Patients With Early Breast Cancer: An Individual Participant Data and Trial-Level Meta-analysis
por: Gulia, Seema, et al.
Publicado: (2020)

Authors’ Reply
por: Gupta, Sudeep, et al.
Publicado: (2014)

Is human papillomavirus vaccination likely to be a useful strategy in India?
por: Gupta, Sudeep, et al.
Publicado: (2013)

Geographical & seasonal variation in COVID-19 related mortality
por: Badwe, Rajendra A., et al.
Publicado: (2020)

Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature
por: Soni, Kishan, et al.
Publicado: (2020)

Sterilization Rate of the Axilla After Neoadjuvant Chemotherapy: The Scope for Conservative Surgery
por: Noronha, Jarin, et al.
Publicado: (2020)

Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations
por: Joshi, Asim, et al.
Publicado: (2021)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
por: Nishio, Kazuto, et al.
Publicado: (2021)

Lymphopenia during chemoradiation—foe or friend
por: Patil, Vijay M, et al.
Publicado: (2020)

Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report
por: Godbole, Mukul, et al.
Publicado: (2017)

The prevalence of cognitive impairment in older Indian persons with cancer and brain metastases
por: Dhanawat, Aditya, et al.
Publicado: (2022)

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy
por: Noronha, Vanita, et al.
Publicado: (2017)

Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
por: Tseng, Jeng-Sen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n35qhm7ek0sd01vh9f7iupemf1